Ubaka Ogbogu
Ubaka Ogbogu is an Assistant Professor and the Katz Group Research Fellow in Health Law at the Faculty of Law, University of Alberta. His teaching and research interests include health law, law and biotechnology, law and bioethics, science and regulation, and legal history. Ubaka is a former SCN trainee and a recipient of the SCN Canadian Alumni Award. He has done extensive research work on the ethical, legal and social issues associated with stem cell research, and continues to research and publish in this area. Ubaka holds law degrees at the bachelors and masters levels from the University of Benin in Nigeria and the University of Alberta, and is currently in the process of completing a doctorate in law at the University of Toronto. His doctoral work focuses on the legal history of early health care and biotechnology policies in Canada, particularly in relation to smallpox vaccination and infectious diseases.
Posts by: Ubaka
The Australian government is currently reviewing their stem cell and cloning research laws. The review, which began on December 22, 2010 with the appointment of an independent Legislation Review Committee (LRC) chaired by a retired federal judge, is the second since the enactment in 2002 of the Prohibition of Human Cloning for Reproduction Act and […]
A few weeks ago I blogged about the recent Supreme Court of Canada decision on the constitutional validity of several sections of the Assisted Human Reproduction Act, Canada’s assisted reproduction and embryo research legislation. I am currently preparing a paper for the Health Law Review looking at the impact of the decision on activities regulated by the Act. The paper includes a table […]
A couple of significant updates to report on from the ethics and law arena: On December 22, 2010, the Supreme Court of Canada (SCC) released its long-awaited judgment in the Reference re: Assisted Human Reproduction Act case involving a constitutional challenge brought by the province of Quebec against several sections of the Assisted Human Reproduction […]
In March 2009, in his remarks at the signing of an Executive Order to reverse the Bush-era stem cell research funding restrictions, President Obama directed John P. Holdren, Director of the Office of Science and Technology Policy, to “develop a strategy for restoring scientific integrity to government decision making” by ensuring that science policy is […]
President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President in May following the announcement by the J. Craig Venter Institute of the creation […]
Comments